Characteristic or outcome | Value |
---|---|
Age, years* | 59.8 ± 10.5 |
Gender | |
Male/female, n (%) | 47 (45.2)/57 (54.8) |
Body mass index, Kg/m2* | 24.1 ± 3.1 |
Symptom, n (%) | |
Asymptomatic | 40 (38.5) |
Symptomatic | 64 (61.5) |
Pain | 37 |
Dyspepsia | 12 |
Bleeding | 8 |
Palpable mass | 2 |
Dizziness | 5 |
Tumor location | |
Upper/Middle/Lower, n (%) | 61 (58.7)/24 (23.0)/19 (18.3) |
Tumor size, cm* | 5.1 ± 3.3 |
Prognostic group†, n (%) | |
Group 1 | 10 (9.6) |
Group 2 | 49 (47.1) |
Group 3a | 15 (14.4) |
Group 3b | 0 (0) |
Group 4 | 0 (0) |
Group 5 | 9 (8.7) |
Group 6a | 14 (13.5) |
Group 6b | 7 (6.7) |
Operation, n (%) | |
Laparoscopy/open | 80 (76.9)/24 (23.1) |
Type of resection | |
Wedge resection | 90 (86.5) |
Partial gastrectomy | 9 (8.7) |
Total gastrectomy | 5 (4.8) |
Status of surgical margin, n (%) | |
Positive/negative | 0 (0)/104 (100) |
Tumor rupture during operation, n (%) | |
No/yes | 104 (100)/0 (0) |
Operation times (minutes)* | |
Laparoscopy | 91.1 ± 57.0 |
Open | 165.8 ± 75.6 |
Length of hospitalization (days)* | |
Laparoscopy | 4.6 ± 2.3 |
Open | 9.8 ± 4.1 |
Complication, n (%) | |
Yes/no | 1 (1.0)/103 (99.0) |
Recurrence | |
Yes/no | 5 (4.8)/99 (95.2) |
Median follow-up period, months, mean (range) | 49.3 (8.4, 164.4) |